About KolateAI PharmaTech Inc
Patient Stratification for Precision Medicine - Patient clustering during a study will help sponsors identify patient cohorts that show a high drug response with the least number of adverse events. - This precision medicine technique can be used to boost trial success rates and drug efficacy (similar to how a biomarker is used for drug prescription, e.g. Keytruda with PD-L1 biomarker) to reduce unwanted prescriptions and increase payer reimbursement; the marketing label will state who is eligible to take the drug
- Founded
- 2023
- Employees
- 1 to 10
- Total funding
- $150K
- Headquarters
- United States
Leadership
The top of KolateAI PharmaTech Inc's org chart, with how many people report into each leader.
VB
Vinodh Balaraman
Co-Founder & CEO
Jobs at KolateAI PharmaTech Inc
No open positions right now. Explore more companies on TheJobsMap.